• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

How behavioural design is transforming the role and impact of life sciences in healthcare

Share:

August 7, 2018

Behavioural economics will become essential to the future success of life sciences companies

The next revolution in healthcare will be driven by behavioural change.

The healthcare sector is undergoing a historic shift in the face of increasing pressures, which is, in large part, being driven by people’s behaviour. Non-adherence, for example, costs up to US$290m in the US alonei, and studies estimate that up to 40% of deaths from top chronic diseases are preventable through lifestyle changesII. Considering the size of this opportunity, the sector has been slow to invest, with behavioural change often being an afterthought for healthcare organisations.

Incentives to behave rationally are everywhere, from the way products are priced to how we are encouraged to behave at work, but the vast majority of these incentives assume that people are ‘rational agents’ who act in their own best interests. However, research has shown that when it comes to human behaviour, we often act instinctively and irrationally. The good news is that principles of behavioural economics can help us develop customer engagement strategies, services and solutions that overcome these impulses and irrationalities.

The time to design for better health outcomes is now

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Behavioural economics is increasingly being used in wellness, with start-ups helping people to improve diet and exercise through setting goals, making financial pledges and selecting supporters to track their progress. This trend will amplify quickly, as three factors help accelerate the change:

1. Changing healthcare incentives: In order to bring costs under control, governments and insurance companies are moving towards paying for health outcomes. This will force life sciences companies to support patients with behaviour change in order to improve health outcomes in a real-world setting.

2. The rise of digital technologies: Technologies that empower patients and leverage real-time information through apps, wearables, sensors and social media are on the rise. These seamlessly connect patients and doctors, enabling prevention and real-time disease management in a more cost-effective way.

3. The rise of design thinking: As business problems and the contexts people operate in have become more complex and multifaceted, design thinking has gained prominence for putting the user at the centre of the solution.

While organisations are experimenting, we are yet to see healthcare accelerate the adoption of behavioural economics. The first movers that manage to do so successfully are likely to see huge improvements in performance, while also addressing a number of society’s biggest challenges.

Making behavioural change stick in life sciences will require new capabilities

Through work with industry leaders across life sciences, retail and government, we have identified what we believe to be the five key factors in driving long-term change:

1. Understand current behaviours: Combine a range of research techniques to get to the heart of what influences patient and healthcare professionals.

2. Ground behavioural change in the science: Build interventions based on the latest studies in academia, business and patient research, and tailor these to your specific needs.

3. Own the experience: The healthcare sector is incredibly fragmented. Helping to join up the end-to-end experience presents a significant opportunity for organisations to grow their influence within the ecosystem.

4. Don’t lose sight of business value: Every intervention needs to be tied back to a measurable business impact, helping to allocate investment into scaling those that drive value.

5. Adopt an agile, continuous design cycle: Take a responsive approach, where the right interventions are built, tested and implemented at pace.

The way forward

The case for behavioural economics will become essential to the future success of life sciences companies. As policy-makers and payers continue to demand better value for money and outcomes, companies across the health ecosystem will increasingly find themselves in the business of delivering health outcomes. When they do, having the capability to understand customers at a deeper level and then putting in place the right strategies to nudge people to make healthier decisions will be just as important as having an innovative product.

Date: August 7, 2018

Source: pmlive

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Fear of Artificial Intelligence in Healthcare Can Delay BenefitsFear of Artificial Intelligence in Healthcare Can Delay Benefits
  • Mentice to Acquire Eqip and MyIRlog™Mentice to Acquire Eqip and MyIRlog™
  • J.H. Whitney Announces the Sale of AccupacJ.H. Whitney Announces the Sale of Accupac
  • 94% of Healthcare Execs Say AI, Blockchain Have Advanced Innovation94% of Healthcare Execs Say AI, Blockchain Have Advanced Innovation
  • How Digital Health can Help Reduce Anxiety During the COVID-19 PandemicHow Digital Health can Help Reduce Anxiety During the COVID-19 Pandemic
  • Therapeutic Solutions International Acquires Stem Cell Therapy That Successfully Completed FDA Double Blind Placebo Controlled Efficacy Study for Lung DiseaseTherapeutic Solutions International Acquires Stem Cell Therapy That Successfully Completed FDA Double Blind Placebo Controlled Efficacy Study for Lung Disease
  • Improving health outcomes by tackling health literacy: NHS Scotland focusImproving health outcomes by tackling health literacy: NHS Scotland focus
  • Extherid Biosciences has merged with Perfectus Biomed in the UK to form Perfectus Biomed GroupExtherid Biosciences has merged with Perfectus Biomed in the UK to form Perfectus Biomed Group

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications